Regulatory Insights and Strategies for Platform Therapeutics

Terri Shieh-Newton, PhD, is a Mintz Member who guides clients on portfolio management and landscape analysis. She's a trained immunologist with a PhD in Cellular and Molecular Medicine, and she works with companies of all sizes in a wide range of life sciences and clean technology industries.

Former Deputy Director, Office of Biotechnology Products, FDA

SVP Tech Ops and Manufacturing, bit.bio

Director, Human Health Content and Innovation, SynBioBeta